The efficacy of ethylmethylhydroxypyridine in the rehabilitation treatment of poststroke patients

Zhuravleva M.V.; Prokofiev A.B.; Arkhipov V.V.; Serebrova S.Yu.; Gorodetskaya G.I.; Demidova O.A.

doi:https://doi.org/10.17116/jnevro202012003192

Zhuravleva M.V.

Federal State Autonomous Educational Institution of Higher Education I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russia, Moscow, Russia

Prokofiev A.B.

I.M. Sechenov First Moscow State Medical University, Moscow, Russia;
Private Dermatovenerologic Clinic, Svidnik, Slovak Republic;
Federal State Budgetary Institution “Scientific Centre for Expert Evaluation of Medicinal Products” of the Ministry of Health of the Russian Federation, Moscow, Russia

Arkhipov V.V.

Research center for examination of medical devices, Moscow, Russia

Serebrova S.Yu.

I.M. Sechenov First Moscow State Medical University, Ministry of Healthcare of the Russia, Moscow, Russia, 119991;
Scientific Center for Expertise of Medical Products, Ministry of Healthcare of the Russia, Moscow, Russia, 127051

Gorodetskaya G.I.

Demidova O.A.

Research center for examination of medical devices, Moscow, Russia

The efficacy of ethylmethylhydroxypyridine in the rehabilitation treatment of poststroke patients

Authors:

Zhuravleva M.V., Prokofiev A.B., Arkhipov V.V., Serebrova S.Yu., Gorodetskaya G.I., Demidova O.A.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2020;120(3): 92‑96

DOI: 10.17116/jnevro202012003192

Read: 5934 times

To cite this article:

Zhuravleva MV, Prokofiev AB, Arkhipov VV, Serebrova SYu, Gorodetskaya GI, Demidova OA. The efficacy of ethylmethylhydroxypyridine in the rehabilitation treatment of poststroke patients. S.S. Korsakov Journal of Neurology and Psychiatry. 2020;120(3):92‑96. (In Russ., In Engl.)
https://doi.org/10.17116/jnevro202012003192

Подписка 2026 Журнал неврологии и психиатрии им. С.С. Корсакова (S.S. Korsakov Journal of Neurology and Psychiatry)

Использование инфографики авторами научных работ

Close metadata

Recommended articles:

Asthenia in the acute period of ischemic stroke. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(3-2):5-10

Effectiveness of comprehensive rehabilitation of patients after a stroke in terms of changes in clinical and functional characteristics. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(3-2):11-16

Methods for determining the extent of ischemic changes in brain matter in the prognosis of clinical outcome after successful thromboextraction. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(3-2):17-27

Confirmation of the competitive validity of the Russian Aphasiological Test, a new standardized tool for the diagnosis of aphasia. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(3-2):28-34

Cerebrolysin and the optimal timing of anticoagulation resumption in stroke: combined post hoc survival analysis of the CEREHETIS trial. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(3-2):77-93

Hand burns in pediatrics. Pirogov Russian Journal of Surgery. 2025;(3):96-106

Prevalence of cerebrovascular diseases risk factors according to the cohort survey data in Bishkek, Kyrgyz Republic. Russian Journal of Preventive Medicine. 2025;(3):34-39

Possibilities of vibroacoustic therapy application in patients with chronic bronchopulmonary pathology. Problems of Balneology, Physiotherapy and Exercise Therapy. 2025;(1):12-18

Rehabilitation of patients with post-COVID syndrome depending on C(159)T polymorphism of SD-14 gene. Problems of Balneology, Physiotherapy and Exercise Therapy. 2025;(1):42-50

Effectiveness of muscles’ preoperative preparation for reconstruction of anterior cruciate ligament of knee. Problems of Balneology, Physiotherapy and Exercise Therapy. 2025;(1):51-57

Abstract:

The analysis of the clinical efficacy and safety of ethylmethylhydroxypyridine succinate (mexidol) in the complex of rehabilitation measures in patients after ischemic stroke (IS) shows that course treatment with mexidol improves the recovery of neurological functions, decreases neurological deficit, cognitive disorders, including memory impairment, and manifestations of asthenic syndrome, increases the level of social adaptation and improves the psycho-emotional state of patients, reduces spasticity, increases motor and speech activity, praxis, reliably eliminates the ignoring syndrome. There is a decrease in the level of total cholesterol and low-density b-lipoproteins in the blood, and decrease in the severity of hypercoagulation. The results of the studies have convincingly shown the efficacy of mexidol at all stages of rehabilitation treatment of patients with IS.

Keywords:

ethylmethylhydroxypyridine succinate

mexidol

rehabilitation

recovery

stroke

Authors:

Zhuravleva M.V.

Federal State Autonomous Educational Institution of Higher Education I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russia, Moscow, Russia

Prokofiev A.B.

Arkhipov V.V.

Research center for examination of medical devices, Moscow, Russia

Serebrova S.Yu.

Gorodetskaya G.I.

Demidova O.A.

Research center for examination of medical devices, Moscow, Russia

Close metadata

References:

Gusev EI, Martynov MYu, Kamchatnov PR. Ishemicheskij insul’t. Sovremennoe sostoyanie problemy. Doktor ru. 2013;5:83:7-12. (In Russ.).
Gusev EI, Skvorczova VI, Stakhovskaya LV. Epidemiology of stroke in Russia. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova. Insul`t. 2003;8:4–9. (In Russ.).
Gusev EI, Skvorcova VI. Ishemiya golovnogo mozga. M: Medicina. 2001. (In Russ.).
Kamchatnov PR, Tyazhel`nikov AA, Osmaeva ZKh, Chugunov AV. Nejrometabolicheskie preparaty` v kompleksnoj terapii czerebrovaskulyarny`kh zabolevanij. Vrach. 2018;29(11):59–63. (In Russ.). https://doi.org/10.29296/25877305-2018-11-12
Karpikova NI, Peteryuhina AA. Primenenie preparata «Meksidol®» dlya lecheniya bol’nyh s zabolevaniyami sosudov golovnogo mozga. Byulleten’ eksperimental’noj biologii i mediciny. 2006;(supl 1):32-33. (In Russ.).
Kuznecova SM, Kuznecov VV, Yurchenko FV. Meksidol v reabilitacii bol’nyh pozhilogo vozrasta, perenesshih insul’t. Farmateka. 2009;15:105-108. (In Russ.).
Tanashyan MM, Lagoda OV, Antonova KV. Chronic cerebrovascular diseases on the background of metabolic syndrome: new approaches to treatment. Zhurnal Nevrologii i Psihiatrii im. S.S. Korsakova. 2012;112(11):21-26. (In Russ.).
Abylaeva MT. Primenenie preparata meksidol v kompleksnom lechenii postinsul’tnyh rasstrojstv. Vestnik KAZNMU. 2012;2:37-38. (In Russ.).
Koval’chuk VV. Nejrometabolicheskaya terapiya kak sredstvo vtorichnoj profilaktiki insul’ta. Zhurnal nevrologii i psihiatrii im. S.S. Korsakova. 2014;114(3):24-28. (In Russ.).
Koval’chuk VV. Effect of Mexidol on neurological deficits, social adaptation, and non-eclectic and «repulsive» syndromes in patients after stroke. Zhurnal nevrologii i psihiatrii im. S.S. Korsakova. 2011;12(2):52-57. (In Russ.).
Kuznecova EB, Salina EA, Sholomov II. Possibility of correction of cognitive disorders in the course of complex treatment of patients with the consequences of a brain infarction. Zhurnal nevrologii i psihiatrii im. S.S. Korsakova. 2015;115(11):103-106. (In Russ.).
Kuznecov VV, Yurchenko FV. Features of the effect of Mexidol on the functional state of the Central nervous system in patients who have suffered a stroke. Zhurnal nevrologii i psihiatrii im. S.S. Korsakova. 2012;6:18-20. (In Russ.).
Kispaeva TT. Preventive and therapeutic correction of the formation and progression of cognitive deficits in stroke patients. Zhurnal nevrologii i psihiatrii im. S.S. Korsakova. 2013;113(7):76-79. (In Russ.).
Koval’chuk VV, Skoromets AA. Vozmozhnosti Meksidola pri vosstanovlenii patsientov posle insul’ta. Medlajn-ehkspress. 2009;4-5(203):4-6. (In Russ.).